Editas Medicine
Price & Volume
Stats
See more52W Range | $0.91-$4.53 |
Market Cap | $213.7M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $46.3M |
Revenue Growth (YoY) | 12,265.6% |
Gross Profit (12 Mos) | -$64.7M |
Diluted EPS | -$2.35 |
News
See moreYahoo Finance • 3 months ago
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
Yahoo Finance • 4 months ago
Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate
Yahoo Finance • 4 months ago
Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate
Yahoo Finance • 4 months ago
Vanguard Consumer Staples Breaks Below 200-Day Moving Average - Notable for VDC
About
CEO | Dr. Gilmore O'Neill M.D. |
CFO | Ms. Amy Parison |
Address | 11 Hurley Street, Cambridge, MA, United States, 02141 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 246 |
